Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Perspective Therapeutics focuses on advancing cancer treatments employing radiation, radiopharmaceuticals, and imaging technology.
CORXEL Pharmaceuticals is a biotechnology company that develops science and medicines for underserved patients.
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Century Therapeutics is a biotechnology company that develops cell therapies for hematological and solid tumor malignancies.
Beacon Therapeutics is a biotechnology company that develops treatments to preserve and restore vision for rare and prevalent eye diseases.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.
Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.
Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products.
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with rare and prevalent diseases.
Cidara Therapeutics develops targeted immunotherapies aimed at improving treatment outcomes for patients with serious diseases.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Mineralys Therapeutics is a clinical-stage biopharmaceutical company committed to developing therapy for the treatment of hypertension.
Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.
Plexium develops a targeted protein degradation platform to find new therapies for cancer and other diseases.
Abivax develops medicines that alter the body's natural immune system mechanisms.
Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.
ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Inhibrx is a clinical-stage biotechnology company that focuses on developing a broad pipeline of biologic therapeutic candidates.
ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs.
Avalo Therapeutics is a clinical-stage biopharmaceutical company.
Vicebio is a biopharmaceutical company developing next-generation respiratory virus vaccines using the Molecular Clamp technology.
Pathalys is a clinical biopharmaceutical company that develops therapeutics that improve late-stage chronic kidney disease.
TCG Crossover has invested in 81 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
TCG Crossover's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Pharmaceutical. The firm invests across 12 different industry categories.
Among tracked funding rounds, Structure Therapeutics received $747.5M in a Post Ipo Equity round. TCG Crossover's total known invested capital is $14.3B.
TCG Crossover's average investment size is $176.4M across its portfolio of 81 companies.
Recent TCG Crossover portfolio additions include Perspective Therapeutics, CORXEL Pharmaceuticals, Mirador Therapeutics, Century Therapeutics, Beacon Therapeutics. These companies were founded in 2020 or later.